Published in Urology on September 20, 2009
Ultrasound-guided intramural inoculation of orthotopic bladder cancer xenografts: a novel high-precision approach. PLoS One (2013) 0.87
Imaging deep skeletal muscle structure using a high-sensitivity ultrathin side-viewing optical coherence tomography needle probe. Biomed Opt Express (2013) 0.87
Assessment of anti-inflammatory tumor treatment efficacy by longitudinal monitoring employing sonographic micro morphology in a preclinical mouse model. BMC Med Imaging (2011) 0.77
Robotic real-time near infrared targeted fluorescence imaging in a murine model of prostate cancer: a feasibility study. Urology (2013) 2.15
Primary lymphoepithelioma-like carcinoma of the ureter. Ann Diagn Pathol (2009) 2.11
Radiolabeled small-molecule ligands for prostate-specific membrane antigen: in vivo imaging in experimental models of prostate cancer. Clin Cancer Res (2005) 2.10
Lack of pathologic down-staging with neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder: a contemporary series. Cancer (2009) 2.02
Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management. Urology (2011) 1.78
Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy. Cancer (2010) 1.77
Interobserver reproducibility in the diagnosis of invasive micropapillary carcinoma of the urinary tract among urologic pathologists. Am J Surg Pathol (2010) 1.73
Targeted elimination of prostate cancer by genetically directed human T lymphocytes. Cancer Res (2005) 1.67
The investigational Aurora kinase A inhibitor MLN8237 induces defects in cell viability and cell-cycle progression in malignant bladder cancer cells in vitro and in vivo. Clin Cancer Res (2013) 1.62
Sunitinib malate provides activity against murine bladder tumor growth and invasion in a preclinical orthotopic model. Urology (2012) 1.45
Primary carcinoid tumors of the testis: a clinicopathologic study of 29 cases. Am J Surg Pathol (2010) 1.41
Utility of a triple antibody cocktail intraurothelial neoplasm-3 (IUN-3-CK20/CD44s/p53) and α-methylacyl-CoA racemase (AMACR) in the distinction of urothelial carcinoma in situ (CIS) and reactive urothelial atypia. Am J Surg Pathol (2013) 1.40
Targeted, activatable, in vivo fluorescence imaging of prostate-specific membrane antigen (PSMA) positive tumors using the quenched humanized J591 antibody-indocyanine green (ICG) conjugate. Bioconjug Chem (2011) 1.37
KiSS1 suppresses metastasis in human ovarian cancer via inhibition of protein kinase C alpha. Clin Exp Metastasis (2005) 1.33
Role of cystitis cystica et glandularis and intestinal metaplasia in development of bladder carcinoma. Urology (2008) 1.30
Differentiation of a highly tumorigenic basal cell compartment in urothelial carcinoma. Stem Cells (2009) 1.30
CD24 offers a therapeutic target for control of bladder cancer metastasis based on a requirement for lung colonization. Cancer Res (2011) 1.28
Squamous cell carcinoma of the bladder: a clinicopathologic analysis of 45 cases. Am J Surg Pathol (2007) 1.26
Differences in survival for patients with resectable versus unresectable metastases from pancreatic islet cell cancer. J Gastrointest Surg (2006) 1.22
Carcinoma of the collecting ducts of Bellini and renal medullary carcinoma: clinicopathologic analysis of 52 cases of rare aggressive subtypes of renal cell carcinoma with a focus on their interrelationship. Am J Surg Pathol (2012) 1.21
A novel mitogenic protein that is highly expressed in cells of the gastric antrum mucosa. Am J Physiol Gastrointest Liver Physiol (2003) 1.20
Urethral diverticula in 90 female patients: a study with emphasis on neoplastic alterations. J Urol (2008) 1.19
Histopathologic features and clinical outcomes in 71 cases of bladder diverticula. Arch Pathol Lab Med (2009) 1.19
ICUD-EAU International Consultation on Bladder Cancer 2012: Pathology. Eur Urol (2012) 1.19
Global expression analysis of well-differentiated pancreatic endocrine neoplasms using oligonucleotide microarrays. Clin Cancer Res (2003) 1.18
Foregut duplication cyst of the stomach. J Gastrointest Surg (2006) 1.14
PARP inhibition sensitizes to low dose-rate radiation TMPRSS2-ERG fusion gene-expressing and PTEN-deficient prostate cancer cells. PLoS One (2013) 1.06
Von Hippel Lindau syndrome. Adv Exp Med Biol (2010) 1.04
Comparative gene expression profiling analysis of urothelial carcinoma of the renal pelvis and bladder. BMC Med Genomics (2010) 1.03
Temporal differences in bladder dysfunction caused by diabetes, diuresis, and treated diabetes in mice. Am J Physiol Regul Integr Comp Physiol (2006) 1.00
HER2 gene amplification occurs frequently in the micropapillary variant of urothelial carcinoma: analysis by dual-color in situ hybridization. Mod Pathol (2011) 0.98
Glutamate carboxypeptidase II levels in rodent brain using [125I]DCIT quantitative autoradiography. Neurosci Lett (2005) 0.98
Primary bladder amyloidosis--case report of a patient with delayed upper urinary tract obstruction 3 years after the diagnosis. Amyloid (2010) 0.97
Non-epithelial neoplasms of the prostate. Histopathology (2012) 0.97
Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder. Hum Pathol (2008) 0.97
Aberrant diffuse expression of p63 in adenocarcinoma of the prostate on needle biopsy and radical prostatectomy: report of 21 cases. Am J Surg Pathol (2008) 0.97
Emerging concepts in micropapillary urothelial carcinoma. Adv Anat Pathol (2010) 0.96
Mutation of NIMA-related kinase 1 (NEK1) leads to chromosome instability. Mol Cancer (2011) 0.96
Optimizing orthotopic bladder tumor implantation in a syngeneic mouse model. J Urol (2009) 0.95
Metabolic and antiproliferative consequences of activated polyamine catabolism in LNCaP prostate carcinoma cells. J Biol Chem (2004) 0.94
Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines. Hum Mol Genet (2010) 0.94
Clinical outcomes of augmentation cystoplasty in patients suffering from ketamine-related bladder contractures. Int Urol Nephrol (2013) 0.93
Folate hydrolase (prostate-specific membrane [corrected] antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature. Mod Pathol (2011) 0.93
Mammalian target of rapamycin complex 2 (mTORC2) is a critical determinant of bladder cancer invasion. PLoS One (2013) 0.92
Selective immunohistochemical markers to distinguish between metastatic high-grade urothelial carcinoma and primary poorly differentiated invasive squamous cell carcinoma of the lung. Arch Pathol Lab Med (2012) 0.91
Diagnostic use of antibody to smoothelin in the recognition of muscularis propria in transurethral resection of urinary bladder tumor (TURBT) specimens. Am J Surg Pathol (2010) 0.91
Ganglioneuroma of the adrenal gland. J Urol (2009) 0.90
The relationship of vascular endothelial growth factor and coagulation factor (fibrin and fibrinogen) expression in clear cell renal cell carcinoma. Urology (2009) 0.89
Prognostic value of cell-cycle regulation biomarkers in bladder cancer. Semin Oncol (2012) 0.88
Design and synthesis of a PSMA inhibitor-doxorubicin conjugate for targeted prostate cancer therapy. ChemMedChem (2006) 0.87
Aggregate lymph node metastasis diameter and survival after radical cystectomy for invasive bladder cancer. Urology (2009) 0.86
Vulnerability of continence structures to injury by simulated childbirth. Am J Physiol Renal Physiol (2011) 0.85
Phorbol ester-induced apoptosis of C4-2 cells requires both a unique and a redundant protein kinase C signaling pathway. J Biol Chem (2004) 0.84
Immunohistochemical profile to distinguish urothelial from squamous differentiation in carcinomas of urothelial tract. Hum Pathol (2012) 0.84
Autophagic flux determines cell death and survival in response to Apo2L/TRAIL (dulanermin). Mol Cancer (2014) 0.84
Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder. Am J Surg Pathol (2008) 0.84
Improving the biodistribution of PSMA-targeting tracers with a highly negatively charged linker. Prostate (2014) 0.84
Sarcomatoid Urothelial Carcinoma of the Bladder: Analysis of 28 Cases With Emphasis on Clinicopathologic Features and Markers of Epithelial-to-Mesenchymal Transition. Arch Pathol Lab Med (2016) 0.83
Mixed epithelial and stromal tumor of the kidney. J Urol (2009) 0.82
Loss of p27 nuclear expression in a prognostically favorable subset of well-differentiated pancreatic endocrine neoplasms. Am J Clin Pathol (2003) 0.82
The sensitivity of initial transurethral resection or biopsy of bladder tumor(s) for detecting bladder cancer variants on radical cystectomy. J Urol (2012) 0.81
Uroplakin II outperforms uroplakin III in diagnostically challenging settings. Histopathology (2014) 0.81
The prevalence of lower urinary tract symptoms in a Chinese population, and the correlation with uroflowmetry and disease perception. Int Urol Nephrol (2013) 0.80
Clear cell sarcoma of the kidney. J Urol (2011) 0.80
Pneumovesicum approach to en-bloc laparoscopic nephroureterectomy with bladder cuff excision for upper tract urothelial cancer: midterm oncological results. J Endourol (2011) 0.80
Prognostic factors in urothelial carcinoma of the bladder: histologic and molecular correlates. Adv Anat Pathol (2015) 0.80
The role of HLA-G in gastrointestinal inflammatory disease and malignancy. Semin Cancer Biol (2007) 0.78
Small cell bladder cancer: biology and management. Semin Oncol (2012) 0.78
Congenital mesoblastic nephroma. J Urol (2010) 0.78
Utility of diagnostic and prognostic markers in urothelial carcinoma of the bladder. Adv Anat Pathol (2009) 0.77
Diagnostically challenging cases: what are atypia and dysplasia? Urol Clin North Am (2013) 0.77
Clinicopathologic characteristics of 23 cases of invasive low-grade papillary urothelial carcinoma. Urology (2012) 0.77
NAAG peptidase inhibitors and deletion of NAAG peptidase gene enhance memory in novel object recognition test. Eur J Pharmacol (2012) 0.76
Presacral and retroperitoneal lymph node involvement in urothelial bladder cancer: results of a prospective mapping study. J Urol (2011) 0.76
Editorial comment. Urology (2010) 0.75
A Dual Color Immunohistochemistry Assay for Measurement of Cereblon in Multiple Myeloma Patient Samples. Appl Immunohistochem Mol Morphol (2015) 0.75
Validation of new AJCC exclusion criteria for subepithelial prostatic stromal invasion from pT4a bladder urothelial carcinoma. J Urol (2012) 0.75
Postoperative gastric rupture in children with cerebral palsy. J Pediatr Orthop (2005) 0.75
Epidermoid cyst of the testicle. Urology (2009) 0.75
Cystinuria: a rare diagnosis that should not be missed. Hong Kong Med J (2008) 0.75
Influence of histologic criteria and confounding factors in staging equivocal cases for microscopic perivesical tissue invasion (pT3a): an interobserver study among genitourinary pathologists. Am J Surg Pathol (2014) 0.75
Analysis of T1 Bladder Cancer on Biopsy and Transurethral Resection Specimens: Comparison and Ranking of T1 Quantification Approaches to Predict Progression to Muscularis Propria Invasion. Am J Surg Pathol (2017) 0.75
The Symphony protocol for H&E staining of prostatic adenocarcinoma on needle biopsy: a multicentre analysis of 120 cases. Pathology (2008) 0.75
Serous Carcinoma Mimicking Primary Urothelial Carcinoma on Clinical Evaluation and Pathology: A Potential Diagnostic Pitfall. Arch Pathol Lab Med (2017) 0.75